Parkside Financial Bank & Trust Decreases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Parkside Financial Bank & Trust trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 6.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,369 shares of the healthcare conglomerate’s stock after selling 221 shares during the quarter. Parkside Financial Bank & Trust’s holdings in UnitedHealth Group were worth $1,731,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in UNH. Advocacy Wealth Management Services LLC raised its position in shares of UnitedHealth Group by 75.8% during the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. raised its position in UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares during the period. Rise Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth about $38,000. Evolution Advisers Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth about $38,000. Finally, Cordant Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth about $45,000. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the transaction, the chief executive officer now owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Dirk C. Mcmahon sold 14,715 shares of the firm’s stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $543.32, for a total transaction of $7,994,953.80. Following the sale, the chief executive officer now owns 50,108 shares in the company, valued at $27,224,678.56. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the sale, the chief executive officer now owns 76,559 shares in the company, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders sold a total of 139,051 shares of company stock valued at $74,450,958 over the last 90 days. Insiders own 0.40% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Argus upped their target price on shares of UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research note on Monday, July 25th. Loop Capital initiated coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 target price on the stock. Oppenheimer upped their target price on shares of UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Finally, Sanford C. Bernstein downgraded shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price on the stock. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $586.40.

UnitedHealth Group Trading Up 1.1 %

NYSE UNH opened at $517.46 on Friday. The company has a fifty day simple moving average of $530.11 and a two-hundred day simple moving average of $512.45. The stock has a market cap of $484.02 billion, a P/E ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s quarterly revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the company posted $4.70 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were issued a dividend of $1.65 per share. The ex-dividend date was Friday, September 9th. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.